Then, we explored FUS protein level in the metastatic nodules with immunohistochemistry (IHC), and found that FUS was significantly reduced in the lung and liver metastatic nodules from ESCC cells with downregulated GTF2E2. The gene discussed is FUS; the disease is esophageal squamous cell carcinoma.